May 27, 2026
2 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
Novel neurotrophin-3 inhibitor yields significant reductions in knee osteoarthritis pain
A novel neurotrophin-3 inhibitor significantly reduced pain and improved function vs. placebo for patients with knee osteoarthritis, according to results presented at the Osteoarthritis Research Society International World Congress. LEVI-04 (Levicept) is a p75 neurotrophin receptor-Fc fusion protein that inhibits neurotrophin-3 to treat pain in patients with knee OA.
636 words~3 min read
